Insider · CIK 0002047489
Jeff Chiprin
Files at IRMD (IRADIMED CORP). First filing -, latest -.
In brief
Jeff Chiprin files SEC Form 4 as officer at IRMD (IRADIMED CORP). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jeff Chiprin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | IRMD IRADIMED CORP | AGrant or award Restricted Stock Unitsderivative | +1,150 | $0.00 | $0 | 1,150 | Mar 5, 2026 |
| Dec 11, 2025 | IRMD IRADIMED CORP | MOption exercise Common Stock | +996 | - | - | 996 | Dec 12, 2025 |
| Dec 11, 2025 | IRMD IRADIMED CORP | FTax withholding Common Stock | -309 | $97.38 | $30k | 687 | Dec 12, 2025 |
| Dec 11, 2025 | IRMD IRADIMED CORP | MOption exercise Restricted Stock Unitsderivative | -996 | $0.00 | $0 | 1,994 | Dec 12, 2025 |
| Dec 11, 2024 | IRMD IRADIMED CORP | AGrant or award Restricted Stock Unitsderivative | +2,990 | $0.00 | $0 | 2,990 | Dec 13, 2024 |
| Dec 11, 2024 | IRMD IRADIMED CORP | AGrant or award Performance-based Restricted Stock Unitsderivative | +2,989 | $0.00 | $0 | 2,989 | Dec 13, 2024 |
Questions about Jeff Chiprin
Answered from the filings on this page, as of the latest one.
Is Jeff Chiprin buying or selling?
Jeff Chiprin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jeff Chiprin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeff Chiprin has 0.
Where does Jeff Chiprin file Form 4?
Jeff Chiprin has filed Form 4 at IRMD (IRADIMED CORP) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.